Newsmakers

NexTech’s (OTC: NEXCF) InfernoAR Lands Annual Contract With Real Asset Media as its Video Conference Virtual Events Platform

Virtual Events Video Conferencing and AR Platform to be Levered into Real Estate Market NEW YORK and TORONTO, June 22, 2020  — NexTech AR Solutions (NexTech) (NEXCF) (CSE:NTAR) (N29.F), an emerging leader in augmented reality for eCommerce, […]

Newsmakers

NexTech (OTC: NEXCF) Adds Respirator Supplier O2Canada.com to its Growing Roster of Enterprise Customers for AR Technology Services

More Global Enterprise Customers Choosing NexTech’s Augmented Reality Technologies to Power their E-Commerce Business and Gain Competitive Edge NEW YORK, June 17, Jun 17, 2020  — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]

Newsmakers

ImagineAR (OTC: IPNFF) app Featuring Celebrities Flo Rida and Dwayne Wade Deployed by Broward Schools

Broward Education Foundation unveils “#2020gradsecret” with history-making AR technology that includes a special message from NBA legend Dwyane Wade FORT LAUDERDALE, Fla, June 15, 2020  – Broward Education Foundation teamed up with ImagineAR Inc. (CSE: […]

Newsmakers

CytoDyn (OTC: CYDY) Initiates Phase 2 Clinical Trial With Leronlimab for Treatment of NASH

VANCOUVER, Washington, Jun 11, 2020 — Preclinical results demonstrated leronlimab effectively inhibited fatty liver development VANCOUVER, Washington, June 11, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), […]

Newsmakers

CytoDyn (OTC: CYDY) Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next

VANCOUVER, Washington, June 11, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today the Company […]

Newsmakers

Drs. Pourhassan and Kelly of CytoDyn (OTC: CYDY) to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021

VANCOUVER, Washington, Jun 09, 2020  — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader […]

Newsmakers

ImagineAR (OTC: IPNFF) Announces Augmented Reality Partnership with North Highland, Ranked By Forbes As One Of America’s Best Management Consulting Firms In 2020

VANCOUVER, BC and ERIE, Pa., June 4, 2020  – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables businesses to create their own mobile phone AR campaigns, is pleased to announce the signing […]